Characteristics | Study population (n = 197) | Passive drainage (n = 132) | Closed-suction drainage (n = 65) | ||||
---|---|---|---|---|---|---|---|
No./mean ± SDa | (%) | No./mean ± SDa | (%) | No./mean ± SDa | (%) | p | |
Age (years) | 66.2 ± 11.8 | - | 64.8 ± 11.3 | - | 68.5 ± 11.8 | - | 0.08 |
Male | 108 | (54.8) | 70 | (53.0) | 38 | (58.5) | 0.47 |
Body mass index (kg/m2) | 25.0 ± 4.3 | - | 24.7 ± 4.1 | - | 25.5 ± 4.4 | - | 0.21 |
ASAb score | 0.31 | ||||||
1 | 44 | (22.3) | 34 | (25.0) | 10 | (15.4) | |
2 | 114 | (57.9) | 75 | (56.8) | 39 | (60.0) | |
3 | 39 | (18.3) | 23 | (17.4) | 16 | (24.6) | |
Chronic pancreatitis | 30 | (19.8) | 19 | (14.4) | 12 | (18.5) | 0.46 |
Pathology | <0.01 | ||||||
Adenocarcinoma | 134 | (68.0) | 97 | (73.5) | 37 | (56.9) | |
Cholangiocarcinoma | 7 | (3.6) | 6 | (4.5) | 1 | (1.5) | |
Ampullocarcinoma | 6 | (3.0) | 5 | (3.8) | 1 | (1.5) | |
Other | 50 | (25.4) | 24 | (18.2) | 26 | (40.1) | |
Neoadjuvant treatment | 22 | (11.2) | 13 | (9.8) | 9 | (13.8) | 0.40 |
Pre-operative biliary drainage | 93 | (47.2) | 66 | (50.0) | 27 | (41.5) | 0.26 |
Artery resection | 1 | (0.5) | 1 | (0.8) | 0 | (0) | 1.00 |
Vein resection | 38 | (19.3) | 32 | (24.2) | 6 | (9.2) | 0.01 |
Pylorus preservation | 142 | (72.1) | 106 | (80.3) | 36 | (55.4) | <0.01 |
Type of pancreatic anastomosis | <0.01 | ||||||
Pancreaticogastrostomy | 97 | (49.2) | 79 | (60.3) | 18 | (28.1) | |
Pancreaticojejunostomy | 98 | (49.8) | 52 | (39.7) | 46 | (71.9) | |
Soft pancreatic gland texture | 28 | (14.2) | 18 | (13.6) | 10 | (15.4) | 0.66 |
Main pancreatic duct diameter | 4.93 ± 2.45 | - | 5.0 ± 2.3 | - | 5.1 ± 2.7 | - | 0.79 |
Intra-operative blood loss (mL) | 685 ± 588 | - | 664 ± 519 | - | 728 ± 719 | - | 0.89 |
Blood transfusion | 44 | (22.3) | 28 | (22.8) | 16 | (24.6) | 0.78 |
Operative time (minutes) | 388 ± 125 | - | 339 ± 136 | - | 377 ± 95 | - | 0.16 |
Somatostatin analogs | 89 | 45.2 | 61 | 47.3 | 28 | 43.7 | 0.65 |